Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer
{{output}}
Circulating tumor cells (CTCs) have emerged as a promising biomarker in breast cancer, offering insights into disease progression and treatment response. While CTCs have demonstrated prognostic relevance in early breast cancer, more validation is required to e... ...
